Merck KGaA says its Pharma Raw Materials unit is expanding its activities and has divided the business, earlier this month, into two divisions; biopharma tools, and classical pharma raw materials. The Pharma Raw Materials unit will invest about €8.5 million ($12.7 million) in a new manufacturing facility for process solutions to make biopharmaceuticals at Darmstadt, Germany, and is also setting up a major biopharma R&D facility in the U.S., Merck tells CW. Both facilities are expected to be completed next year. The company is also considering setting up...